We Have Built an Entire Economy Around Making You Sick And Then Selling You the Cure

Picture the perfect customer.

Not a happy customer — happiness is terrible for repeat business. Not a healthy customer either. A healthy customer doesn't need anything. A healthy customer wakes up, moves through their day, eats food that sustains them, sleeps well, and requires very little from the commercial world to maintain that state. A healthy customer is, from the perspective of modern capitalism, a missed revenue opportunity.

The perfect customer is an almost sick customer. Sick enough to keep buying, not sick enough to stop. Fatigued, but functional. Inflamed, but ambulatory. Anxious enough to reach for products that promise relief, but not so incapacitated that they can't make it to the checkout. A customer whose chronic, low-grade suffering creates a permanent, renewable market — who reaches for the energy drink to compensate for the sleep that the stress culture stole, who buys the supplements to correct the deficiencies that the ultra-processed food created, who fills the antacid prescription generated by the diet that the food industry designed, who eventually graduates to the statins, the metformin, the antidepressants that manage, beautifully and profitably, the downstream consequences of a life lived inside systems engineered to produce exactly this outcome.

This is not a conspiracy theory. It does not require shadowy boardrooms or villainous executives twirling metaphorical mustaches.

It is simply what happens when the financial incentives of the world's most powerful industries all point, with quiet unanimity, in the same direction: toward a population that is perpetually unwell, perpetually seeking, and perpetually spending.

And it is working with extraordinary efficiency.

The Architecture of a System That Profits From Sickness

To understand how we arrived here, you have to resist the temptation to look for a single guilty party. The sick-care economy is not the invention of any one industry. It is an emergent property — a pattern that arose from the intersection of multiple powerful commercial forces, each pursuing its own rational self-interest, collectively producing something that no single actor designed but all of them now depend upon.

Start with food. The global ultra-processed food industry is worth over $2 trillion annually. Its products — engineered to be hyperpalatable, nutrient-poor, and chronically craved — are the single largest driver of obesity, type 2 diabetes, cardiovascular disease, and metabolic syndrome in the developed world. This is not contested science. It is the conclusion of thousands of peer-reviewed studies, formal assessments by the World Health Organization, and, increasingly, the industry's own internal research that has been exposed through litigation.

The food industry knows that ultra-processed food makes people sick. It has known, in various forms, for decades. And it has responded to that knowledge not by reformulating its products but by funding nutritional research that muddies the causal waters, lobbying regulatory bodies that might restrict its worst ingredients, marketing aggressively into schools and low-income communities where regulatory oversight is weakest, and donating to public health organizations in ways that create conflicts of interest just profound enough to soften official criticism.

This is the same playbook, executed with the same precision, that the tobacco industry wrote in the 1950s. It is not a coincidence that several of the scientists who pioneered the tobacco industry's doubt-manufacturing strategy later moved, with their expertise and their Rolodexes, into the food industry. The strategy worked for tobacco for fifty years. It has been working for ultra-processed food for longer.

Now follow the money downstream.

The Pharmaceutical Industry's Perfect Business Model

The pharmaceutical industry does not, for the most part, cure disease. This is not an accusation — it is a financial observation. Cures are one-time purchases. A patient who is cured stops buying. A patient who is managed — whose chronic condition is controlled but not resolved, whose symptoms are suppressed but not addressed at the root — is a customer for life. And life, in the language of pharmaceutical economics, is a very long revenue stream.

The global pharmaceutical market is worth approximately $1.5 trillion annually and is projected to exceed $2.3 trillion by 2030. The conditions driving the largest share of that revenue — type 2 diabetes, cardiovascular disease, depression, anxiety disorders, inflammatory conditions, metabolic syndrome — are, in the scientific literature, overwhelmingly lifestyle-related. They are conditions that robust evidence links to diet, physical inactivity, chronic stress, sleep deprivation, and social disconnection. They are conditions that, in many cases, are preventable and reversible through changes in the environments and systems that produce them.

The pharmaceutical industry's solution is not prevention. Prevention, by definition, eliminates the customer before they become one. The industry's solution is pharmacological management — drugs that control blood pressure without addressing the ultra-processed diet raising it, drugs that regulate blood sugar without addressing the food system producing insulin resistance, drugs that suppress the depressive symptoms generated by a culture of chronic stress and isolation without addressing the culture itself.

This is not to say that these drugs are useless — for many people, they are genuinely life-saving. It is to say that a system organized around selling management rather than prevention has a structural incentive to ensure that the conditions being managed are continuously produced. And it operates inside a regulatory and cultural environment that, decade after decade, allocates the overwhelming majority of its healthcare resources to treatment and a fraction — typically 3 to 5 percent of healthcare budgets in most developed nations — to prevention.

We spend the money where the profit is. The profit is not in keeping people well.

The Wellness Industry: The Sickest Joke of All

Here is where it gets almost perversely elegant.

Recognizing — correctly — that the healthcare system is not keeping people well, a significant portion of the population has migrated toward the wellness industry: a $5.6 trillion global marketplace offering supplements, functional foods, clean beauty products, biohacking devices, detox programs, wellness retreats, and an entire media ecosystem of podcasts, influencers, and content platforms dedicated to the project of optimal health.

Much of this industry is, on examination, a reflection of the same machine it positions itself against.

The supplement industry, worth over $170 billion annually, sells correctives to deficiencies that the food system created. Many of the most popular supplements — magnesium, B vitamins, omega-3 fatty acids, vitamin D, zinc — address nutritional gaps that a diet centered on whole, traditionally prepared food would not produce. Rather than fixing the food system, we have built a parallel industry that profits from its failures.

The detox and cleanse industry sells solutions to the problem of toxic exposure — from pesticides, microplastics, food additives, and environmental pollutants — that regulatory capture and corporate lobbying have allowed to accumulate in the food and environment in the first place. Rather than regulating the toxins out of the supply chain, we have created a market for products that promise to flush them out of your body, at personal expense, after the damage is done.

The mental wellness industry sells meditation apps, stress supplements, and digital therapy products to populations whose anxiety, depression, and burnout are, in measurable part, products of the productivity culture, the attention economy, the financial precarity, and the social fragmentation that the same economic system produces. The app does not fix the 60-hour work week. It makes it more endurable. Which is, for everyone invested in the 60-hour work week, precisely the point.

This is the vertically integrated illness economy in its purest form: the same system makes you sick, sells you the acute treatment, and then sells you the wellness products to manage the residue. At no point does anyone in this chain have a financial interest in the outcome where you simply do not get sick in the first place.

The Infrastructure of Manufactured Suffering

The sick-care economy does not run on malice. It runs on infrastructure — the built, institutional, and cultural environment that shapes behavior at scale in ways that produce predictable outcomes.

Consider the physical infrastructure of modern life. Car-dependent suburban sprawl was not designed to minimize physical activity, but that has been its effect — removing walking from daily life as efficiently as any policy could have designed. Sedentary office work was not designed to destroy metabolic health, but combined with ultra-processed food and chronic stress, it does so reliably. Fast food geography — the documented concentration of fast food outlets in low-income areas, near schools, in food deserts where fresh produce is economically and physically inaccessible — is not designed to maximize type 2 diabetes incidence, but it does.

Consider the digital infrastructure. The attention economy — built on engagement metrics, algorithmic amplification of emotionally activating content, and the economic logic that the more anxious and outraged a user, the longer they stay on platform — is not designed to produce anxiety disorders and depression. But it does. Social media platforms have internal research, disclosed through whistleblowers and litigation, showing that their products worsen mental health in adolescents — and they have responded by optimizing the products further, because the engagement numbers hold.

Consider the labor infrastructure. The normalization of chronic overwork, the elimination of recovery time from professional culture, the glorification of exhaustion as evidence of dedication — these are not designed to produce the burnout, sleep deprivation, and stress-related illness that they reliably generate. But the workers who crash and need treatment are replaced, and the healthcare industry is there to provide it, and the productivity culture is there to pressure the recovery into being brief.

The system does not need to intend harm. It only needs to reward the behaviors that produce it and outsource the consequences to individuals and public health systems that absorb the cost.

The Cost That Never Appears on a Balance Sheet

There is a number that the sick-care economy never reports in its earnings calls, never includes in its shareholder updates, never acknowledges in its sustainability disclosures: the cost of the suffering it produces.

In the United States alone, chronic diseases account for 90 percent of the $4.1 trillion spent annually on healthcare. The majority of those chronic diseases are, in the scientific consensus, largely preventable. The human cost of that preventable suffering — the years lost to fatigue, pain, and diminished capacity, the relationships strained by illness, the potential never realized, the lives shortened — is not captured in any economic metric, because the economic system is not designed to measure what it destroys. Only what it sells.

When a child develops type 2 diabetes at fourteen from a lifetime of ultra-processed food marketed to them in every digital space they inhabit, that is not a market failure in the language of the system. The food company profited. The pharmaceutical company will profit. The healthcare system will bill. The GDP will reflect all of it as economic activity. The child's suffering does not appear anywhere that matters to the architecture of incentives.

This is the deepest dysfunction of the sick-care economy: it has successfully externalized the human cost of its operation onto the bodies of the people it serves — and built a cultural narrative in which those bodies, and the choices made within them, bear all the moral responsibility for outcomes that were shaped, at every level, by systems too powerful for any individual to resist alone.

What It Would Take to Actually Change It

The answer is not a better supplement. It is not a wellness retreat. It is not a new diet book or a morning routine or a biohacking protocol, however sincerely those things are offered and however genuinely they help at the margins.

The answer is structural, political, and collective — which is why it is so rarely proposed in the spaces where wellness content lives.

It requires food policy that prioritizes public health over food industry lobbying — sugar taxes, marketing restrictions to children, mandatory front-of-package labeling that is honest rather than decorative, agricultural subsidies redirected from commodity crops that feed ultra-processed food production toward fruit, vegetable, and whole grain farming.

It requires healthcare systems that fund prevention at the level prevention deserves — not 3 percent of the budget, but a genuine structural rebalancing that pays physicians to keep patients healthy rather than to treat them when they are not.

It requires labor policy that treats overwork as the public health crisis it demonstrably is — mandatory rest, right to disconnect legislation, working hour limits enforced rather than advisory.

It requires digital regulation that holds platforms accountable for the mental health consequences of their design choices, the way we hold pharmaceutical companies accountable for the side effects of their drugs.

And it requires, perhaps most fundamentally, a cultural shift in how we assign responsibility — away from the moral failure of the individual who got sick inside a system designed to make them sick, and toward the institutional accountability of the industries and governments that built and maintain that system.

None of this is easy. All of it is necessary.

Because the alternative — the trajectory we are currently on — is a world in which chronic suffering is the most reliable economic growth engine we have, in which the sicker the population, the better the quarterly earnings, in which the highest expression of modern capitalism is the monetization of human bodies in states of managed, profitable, perpetual decline.

We built this. Which means we can unbuild it.

But only if enough people stop buying the cure long enough to start asking who sold them the disease.